NO761477L - - Google Patents
Info
- Publication number
- NO761477L NO761477L NO761477A NO761477A NO761477L NO 761477 L NO761477 L NO 761477L NO 761477 A NO761477 A NO 761477A NO 761477 A NO761477 A NO 761477A NO 761477 L NO761477 L NO 761477L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- trifluoroethyl
- ether
- difluoromethyl
- oxygen
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 18
- 239000001301 oxygen Substances 0.000 claims description 18
- 229910052760 oxygen Inorganic materials 0.000 claims description 18
- OOBHQCBCEJUDAR-UHFFFAOYSA-N 1,1,2,2,3-pentafluoro-3-(1,2,2,3,3-pentafluoropropoxy)propane Chemical compound FC(F)C(F)(F)C(F)OC(F)C(F)(F)C(F)F OOBHQCBCEJUDAR-UHFFFAOYSA-N 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 10
- 206010002091 Anaesthesia Diseases 0.000 claims description 9
- 230000037005 anaesthesia Effects 0.000 claims description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 8
- KQUULKREOKHZAM-UHFFFAOYSA-N 1-(difluoromethoxy)-1,2,2-trifluoroethane Chemical compound FC(F)OC(F)C(F)F KQUULKREOKHZAM-UHFFFAOYSA-N 0.000 claims description 7
- 239000003193 general anesthetic agent Substances 0.000 claims description 6
- 230000003444 anaesthetic effect Effects 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- QJATXYPZRQBEAD-UHFFFAOYSA-N 1,1,2,3,3-pentafluoro-1-(1,1,2,3,3-pentafluoropropoxy)propane Chemical compound FC(F)C(F)C(F)(F)OC(F)(F)C(F)C(F)F QJATXYPZRQBEAD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003570 air Substances 0.000 claims description 4
- 239000001569 carbon dioxide Substances 0.000 claims description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 4
- 239000011261 inert gas Substances 0.000 claims description 4
- 239000003983 inhalation anesthetic agent Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 11
- 241000282326 Felis catus Species 0.000 description 9
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 8
- 229960003132 halothane Drugs 0.000 description 8
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- -1 compound 1,2,2-trifluoroethyl-difluoromethyl ether Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000001949 anaesthesia Methods 0.000 description 2
- 230000002763 arrhythmic effect Effects 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- DLEGDLSLRSOURQ-UHFFFAOYSA-N fluroxene Chemical compound FC(F)(F)COC=C DLEGDLSLRSOURQ-UHFFFAOYSA-N 0.000 description 2
- 229950010045 fluroxene Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- GNRFGTFXHPHBGK-UHFFFAOYSA-M [OH-].[Na+].[O-2].[Ca+2] Chemical compound [OH-].[Na+].[O-2].[Ca+2] GNRFGTFXHPHBGK-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229950011148 cyclopropane Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 description 1
- 229960000305 enflurane Drugs 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000008246 gaseous mixture Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- RFKMCNOHBTXSMU-UHFFFAOYSA-N methoxyflurane Chemical compound COC(F)(F)C(Cl)Cl RFKMCNOHBTXSMU-UHFFFAOYSA-N 0.000 description 1
- 229960002455 methoxyflurane Drugs 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 229960001730 nitrous oxide Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- RZXZIZDRFQFCTA-UHFFFAOYSA-N teflurane Chemical compound FC(Br)C(F)(F)F RZXZIZDRFQFCTA-UHFFFAOYSA-N 0.000 description 1
- 229950010846 teflurane Drugs 0.000 description 1
- AWLILQARPMWUHA-UHFFFAOYSA-M thiopental sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC([S-])=NC1=O AWLILQARPMWUHA-UHFFFAOYSA-M 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960000834 vinyl ether Drugs 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB17698/75A GB1499819A (en) | 1975-04-29 | 1975-04-29 | Anaesthetic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO761477L true NO761477L (fi) | 1976-11-01 |
Family
ID=10099652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO761477A NO761477L (fi) | 1975-04-29 | 1976-04-28 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4113883A (fi) |
| JP (1) | JPS6026767B2 (fi) |
| AU (1) | AU502716B2 (fi) |
| BE (1) | BE841250A (fi) |
| CA (1) | CA1060799A (fi) |
| DE (1) | DE2618958A1 (fi) |
| DK (1) | DK182176A (fi) |
| FI (1) | FI761158A (fi) |
| FR (1) | FR2309214A1 (fi) |
| GB (1) | GB1499819A (fi) |
| IE (1) | IE42794B1 (fi) |
| IL (1) | IL49428A (fi) |
| NL (1) | NL7604137A (fi) |
| NO (1) | NO761477L (fi) |
| NZ (1) | NZ180580A (fi) |
| SE (1) | SE7604892L (fi) |
| ZA (1) | ZA762171B (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4762856A (en) * | 1987-02-02 | 1988-08-09 | Boc, Inc. | Anesthetic composition and method of using the same |
| BE1006433A3 (fr) * | 1992-12-03 | 1994-08-23 | Solvay | Compositions contenant un ether fluore et utilisation de ces compositions. |
| GB9308306D0 (en) * | 1993-04-22 | 1993-06-09 | Univ Aberdeen | Analgesic composition |
| DE10045829A1 (de) * | 2000-09-14 | 2002-04-04 | Messer Griesheim Gmbh | Volatile Anästhesiemittel mit Xenon |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2104756A1 (en) * | 1970-02-03 | 1971-08-19 | National Research Development Corp, London | Fluorinated alkyl and alkeyl etherpretrifluoride from alkyl - and cobalt |
| US3769434A (en) * | 1971-07-02 | 1973-10-30 | Airco Inc | Inhalation anesthetic or analgesic method and composition |
| US3769433A (en) * | 1971-07-02 | 1973-10-30 | Airco Inc | Inhalant anesthetic compositions and method |
-
1975
- 1975-04-29 GB GB17698/75A patent/GB1499819A/en not_active Expired
-
1976
- 1976-04-12 NZ NZ180580A patent/NZ180580A/en unknown
- 1976-04-12 IE IE764/76A patent/IE42794B1/en unknown
- 1976-04-12 ZA ZA762171A patent/ZA762171B/xx unknown
- 1976-04-12 CA CA250,113A patent/CA1060799A/en not_active Expired
- 1976-04-16 US US05/677,855 patent/US4113883A/en not_active Expired - Lifetime
- 1976-04-16 IL IL49428A patent/IL49428A/xx unknown
- 1976-04-20 NL NL7604137A patent/NL7604137A/xx not_active Application Discontinuation
- 1976-04-22 DK DK182176A patent/DK182176A/da not_active Application Discontinuation
- 1976-04-23 AU AU13305/76A patent/AU502716B2/en not_active Expired
- 1976-04-27 FI FI761158A patent/FI761158A/fi not_active Application Discontinuation
- 1976-04-28 BE BE166546A patent/BE841250A/xx not_active IP Right Cessation
- 1976-04-28 NO NO761477A patent/NO761477L/no unknown
- 1976-04-28 FR FR7612586A patent/FR2309214A1/fr active Granted
- 1976-04-28 SE SE7604892A patent/SE7604892L/xx unknown
- 1976-04-29 DE DE19762618958 patent/DE2618958A1/de not_active Withdrawn
- 1976-04-30 JP JP51049793A patent/JPS6026767B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE7604892L (sv) | 1976-10-30 |
| IL49428A0 (en) | 1976-06-30 |
| IE42794B1 (en) | 1980-10-22 |
| NZ180580A (en) | 1984-08-24 |
| AU1330576A (en) | 1977-10-27 |
| IE42794L (en) | 1976-10-29 |
| ZA762171B (en) | 1977-04-27 |
| FR2309214B1 (fi) | 1979-04-27 |
| AU502716B2 (en) | 1979-08-02 |
| BE841250A (fr) | 1976-10-28 |
| JPS6026767B2 (ja) | 1985-06-25 |
| CA1060799A (en) | 1979-08-21 |
| NL7604137A (nl) | 1976-11-02 |
| DE2618958A1 (de) | 1976-11-11 |
| US4113883A (en) | 1978-09-12 |
| FR2309214A1 (fr) | 1976-11-26 |
| JPS51133429A (en) | 1976-11-19 |
| DK182176A (da) | 1976-10-30 |
| IL49428A (en) | 1978-06-15 |
| FI761158A (fi) | 1976-10-30 |
| GB1499819A (en) | 1978-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jones et al. | Clinical impressions and cardiorespiratory effects of a new fluorinated inhalation anaesthetic, desflurane (1–653), in volunteers | |
| Dollery et al. | Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols | |
| CA1309029C (en) | Anesthetic composition and method of using the same | |
| Scott et al. | Plasma lignocaine concentrations following endotracheal spraying with an aerosol | |
| Taylor et al. | Ventricular arrhythmias induced in monkeys by the inhalation of aerosol propellants | |
| Koblin et al. | Are convulsant gases also anesthetics? | |
| NO761477L (fi) | ||
| JP2000516569A (ja) | 生物学的ガス交換用改良ペルフルオロカーボン及び使用方法 | |
| EGLE et al. | Respiratory retention and acute toxicity of furan | |
| Henderson et al. | Washin and washout of isoflurane during cardiopulmonary bypass | |
| Gibbs et al. | Lack of effect of morphine and buprenorphine on hypoxic pulmonary vasoconstriction in the isolated perfused cat lung and the perfused lobe of the dog lung | |
| Sakata et al. | Acute toxicity of fluorocarbon-22: Toxic symptoms, lethal concentration, and its fate in rabbit and mouse | |
| Laster et al. | Visceral losses of desflurane, isoflurane, and halothane in swine | |
| Moriwaki et al. | Partly exhausted soda lime or soda lime with water added, inhibits the increase in compound A concentration in the circle system during low-flow sevoflurane anaesthesia. | |
| BLACK et al. | Respiratory and metabolic changes during methoxyflurane and halothane anaesthesia | |
| Cole et al. | Blood oxygen saturation during anaesthesia with volatile agents vaporized in room air | |
| Standefer | Death associated with fluorocarbon inhalation: report of a case | |
| GRODIN et al. | Halothane adsorption complicating the use of soda-lime to humidify anaesthetic gases | |
| US3883559A (en) | Fluorinated dioxan derivatives | |
| Leakakos et al. | Pulmonary gas trapping differences among animal species in response to intravenous infusion of perfluorocarbon emulsions | |
| Cragg et al. | A fatality associated with trichloroethylene inhalation | |
| Kalman et al. | Minimum alveolar concentration of halothanediethyl‐ether azeotrope | |
| Freeman | Some actions of halothane and ether in bled dogs | |
| Garmer et al. | Some effects of hexafluorobenzene in cats | |
| Halpern | Fluorinated inhalation anesthetics |